Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder

OBJECTIVE: To study rituximab in pediatric neuromyelitis optica (NMO)/NMO spectrum disorders (NMOSD) and the relationship between rituximab, B cell repopulation, and relapses in order to improve rituximab monitoring and redosing. METHODS: Multicenter retrospective study of 16 children with NMO/NMOSD...

Descripción completa

Detalles Bibliográficos
Autores principales: Nosadini, Margherita, Alper, Gulay, Riney, Catherine J., Benson, Leslie A., Mohammad, Shekeeb S., Ramanathan, Sudarshini, Nolan, Melinda, Appleton, Richard, Leventer, Richard J., Deiva, Kumaran, Brilot, Fabienne, Gorman, Mark P., Waldman, Amy T., Banwell, Brenda, Dale, Russell C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723136/
https://www.ncbi.nlm.nih.gov/pubmed/26819962
http://dx.doi.org/10.1212/NXI.0000000000000188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723136/
https://www.ncbi.nlm.nih.gov/pubmed/26819962
http://dx.doi.org/10.1212/NXI.0000000000000188

Ejemplares similares